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BACKGROUND: Mechanisms underlying coffee’s beneﬁcial actions against cardiovascular disease and glucose metabolism are
not well understood. Little information is available regarding association between coffee consumption and adipocytokines.
OBJECTIVE: We investigated potential associations between coffee consumption and adiponectin, leptin, markers for subclinical
inﬂammation, glucose metabolism, lipids and liver enzymes. We then investigated whether adipocytokines played a role in the
association between coffee consumption and these markers.
DESIGN AND SUBJECTS: This is a cross-sectional study comprising 2554 male and 763 female Japanese workers. Potential
relations between coffee consumption and adipocytokines or other markers were evaluated using a multiple linear regression
model adjusted for confounding factors. We evaluated whether adiponectin and leptin partly explain the associations between
coffee consumption and each marker by multiple mediation analysis.
RESULTS: Coffee consumption showed signiﬁcant positive associations with adiponectin and total and low-density lipoprotein
cholesterol, and inverse associations with leptin, high sensitivity C-reactive protein (hs-CRP), triglycerides and liver enzymes
(all Po0.05). An adjustment for adiponectin and leptin signiﬁcantly attenuated the associations between coffee consumption
and hs-CRP or triglycerides, but not for liver enzymes. No associations were observed between coffee consumption and glucose
metabolism-related markers.
CONCLUSION: Coffee consumption was associated with high adiponectin and low leptin levels. We speculated that
adipocytokines mainly explain the associations of coffee consumption with lipids and hs-CRP. Factors other than adipocytokines
may explain the association between coffee consumption and liver function.
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INTRODUCTION
Coffee is one of the world’s most commonly consumed beverages,
and its effects on health have been attracting considerable
attention.
1- -3 An inverse association of coffee consumption with
triglycerides
4,5 and a positive association with high-density
lipoprotein cholesterol levels were previously reported.
6 Con-
sumption of unﬁltered coffee showed greater positive associations
with total cholesterol (TC) and low-density lipoprotein cholesterol
(LDL-C) than ﬁltered coffee.
6 A meta-analysis of 15 large
prospective studies has shown that four or more cups of coffee
consumption per day was associated with a signiﬁcantly lower risk
of type 2 diabetes mellitus (DM).
3 Although it has been speculated
that weight loss,
7 attenuation of subclinical inﬂammation,
8
reduction of oxidative stress
6 and ameliorating effects on liver
function
9,10 might be potential mechanisms underlying the
association, the precise mechanisms remain unknown. A few
studies that assessed the association of coffee consumption with
subclinical inﬂammation showed inconsistent results: positive
11
and negative
8 associations. A short-term clinical trial showed that
C-reactive protein (CRP) levels did not change after coffee
consumption.
6
Adiponectin and leptin are well known to have important roles
in the lipid and glucose metabolisms as well as inﬂammatory
regulation.
12--17 The association between coffee consumption and
adiponectin is still debated. Two cross-sectional studies showed
positive association of coffee consumption with adiponectin,
18,19
whereas one study showed that coffee consumption was not
signiﬁcantly associated with adiponectin levels.
20 In a clinical trial,
adiponectin levels increased after eight cups of coffee per day
compared with 0 cups per day.
6 Few studies have examined the
association of coffee consumption with leptin levels and it remains
to be elucidated.
21 There is a possibility that coffee consumption is
associated with adipocytokines, markers of subclinical inﬂamma-
tion, lipids, glucose metabolism and liver function. Additionally,
we hypothesized that these associations might be explained
partly by adipocytokines.
In this study, we explored the potential association
of coffee consumption with a number of biomarkers,
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MATERIALS AND METHODS
Study sample
The Aichi Workers’ cohort included 6651 civil servants in Aichi Prefecture,
an urban and suburban area located in central Japan between 35 and 69
years of age at recruitment in 2002 (participation rate: 62%). Most of the
cohorts were engaged in clerical work. Police ofﬁcers, ﬁreﬁghters and
public school teachers were not included. Baseline information was
obtained through self-administered questionnaires and mandatory annual
health check-ups provided by the worksite. Participants not consenting to
the use of health check-up data or who did not provide blood sample were
excluded from the present analysis (n¼2570). We further excluded those
without coffee consumption data (n¼52), those with a history of
cardiovascular diseases as well as those who had been on medication
for hypertension, DM or dyslipidemia (n¼732), because the treatment and
associated behavioral change could confound the association between
coffee consumption and blood markers, leaving 2554 men and 763
women eligible for the present analysis. The study protocol was approved
by the Ethics Review Committee of the Nagoya University School of
Medicine.
Main exposure variables
Coffee consumption frequency was assessed by a question item in the
brief dietary history questionnaire that required recall of dietary habits
over 1 month. The possible responses included eight frequency categories:
never, less than one cup per week, one cup per week, two to three cups
per week, four to six cups per week, one cup per day, two to three cups per
day and four or more cups per day. For the descriptive analysis, the lower
ﬁve categories were incorporated into a separate category of less than one
cup per day, because of the small number of the subjects in these
categories. In the multiple linear regression analysis, coffee consumption
frequency was treated as a continuous variable. For each category of
coffee consumption frequency, the following numbers were assigned: 0,
0.05, 0.1, 0.4, 0.7, 1, 2.5 and 4 cups per day, respectively. We also assessed
whether they used sugar in their coffee, categorized as used, not used and
no answer.
Analysis of blood samples
Blood serum samples were drawn from the subjects overnight or after
fasting for at least 8h, and were stored at  801C until biochemical assay.
All the assays were carried out at a commercial laboratory using the
standard procedures. Adiponectin was determined using an enzyme-
linked immunosorbent assay kit (Otsuka Pharmaceutical Co., Ltd, Tokyo,
Japan). The detection limit of the adiponectin assay was 0.40mgml
 1.
Leptin was measured by a radioimmunoassay kit (HUMAN LEPTIN RIA KIT,
Linco Research, Inc., St Charles, IL, USA). The detection limit of the leptin
assay was 0.5ngml
 1, speciﬁcity of the human leptin was 100%.
High sensitivity C-reactive protein (hs-CRP) was measured by latex
nephelometry (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA),
which was sensitive enough to detect 0.02mgl
 1. Tumor necrosis factor-a
(TNF-a) was measured by enzyme immunoassay with a minimum
detectable level of 6pgml
 1 (R&D Systems Inc., Minneapolis, MN, USA).
High-sensitivity interleukin 6 (IL-6) was also measured by enzyme
immunoassay (R&D Systems Inc.).
Fasting blood glucose was enzymatically determined by the hexokinase
method (GLU-HK; Shino-test Corp., Tokyo, Japan). Fasting immunoreactive
insulin was measured by a solid-phase radioimmunoassay (RIABEAD2;
Dinabot Co., Ltd, Chiba, Japan), while a homeostasis model assessment of
insulin resistance (HOMA-IR) was calculated as FBS (mgdl
 1)   fasting
immunoreactive insulin (mUml
 1)/405.
TC and triglycerides were determined enzymatically. High-density
lipoprotein cholesterol was measured by the phosphotungstate method.
LDL-C was measured by an enzymatic method (Cholestest; Sekisui Medical
Co., Ltd, Tokyo, Japan).
Aspartate aminotransaminase, alanine aminotransaminase and gamma-
glutamyl transpeptidase were measured by the consensus method of the
Japan Society of Clinical Chemistry. Intra-assay coefﬁcients of variation of
each variable were as follows: adiponectin, o8.6%; leptin, o1.79%; hs-CRP,
o4.0%; TNF-a, o9.6%; IL-6, o7.5%; Aspartate aminotransaminase, o4.9%;
alanine aminotransaminase, o7.5%; and gamma-glutamyl transpeptidase,
o2.0%. TNF-a and IL-6 were only available for a portion of the studied
sample (n¼691).
Other variables
Height and weight were measured in a standing position at the annual
health check-up, with body mass index (BMI) being calculated as weight in
kilograms divided by the square of the height in meters. Smoking status
was self-reported, and classiﬁed into current, ex- or never smokers. The
number of cigarettes smoked per day was also obtained for current and
ex-smokers. Physically active subjects were deﬁned as those who engaged
in moderate or vigorous exercise for more than 60min per week.
22 Brief
dietary history questionnaire was also used to assess other dietary habits.
Total energy intake, and the intakes of magnesium and alcohol were
calculated using the ad hoc computer algorithm based on the Standard
Table of Food Composition in Japan, ﬁfth revised edition.
23 Consumption
frequency of green tea was assessed using the same categories as coffee
consumption. In the present analysis, they were incorporated into two
categories: one cup or less per day and two or more cups per day. The
estimated glomerular ﬁltration rate (eGFR) was calculated as 194  serum
creatinine
 1.094  Age
 0.287 0.739 (if female) (mlmin
 1 per 1.73 m
2).
24
Statistical analysis
Adipocytokines, inﬂammatory and glucose metabolism-related markers,
lipids, liver enzymes and eGFR were natural logarithmically transformed to
approximately normalize the distribution and used in the analysis, then
transformed back for data presentation, and shown as geometric means
and 95% conﬁdence intervals. A comparison of continuous variables
among coffee consumption groups was conducted by one-way analysis of
variance or covariance adjusted for covariates described below. The linear
trend across coffee consumption categories was evaluated by using the
polynomial procedure of SPSS. Multiple linear regression analysis, taking
adipocytokines, inﬂammatory markers, lipids, glucose metabolism-related
markers and liver enzymes as dependent variables, was also performed to
evaluate the direction and magnitude of associations with coffee
consumption. Independent variables included in the model were age,
BMI, smoking status, cigarettes smoked per day for current smokers,
physical activity, total energy intake, intakes of alcohol, magnesium and
green tea, sugar use in coffee, and eGFR.
Then, we performed the multiple mediation analyses based on the
structure equation modeling using SPSS macros provided by Preacher and
Hayes
25 to examine how much of the association between coffee
consumption and inﬂammatory or glucose metabolism-related markers,
lipids or liver enzymes was attributable to the adipocytokines. Figure 1
shows the multiple mediation model, with path a(s) representing the
relations of coffee consumption (X) to adipocytokines (M(s)), path b(s)
representing the relations of M(s) to each marker (Y(s)) adjusted for X, path
c(s) representing the relations of X to Y(s) and path c(s) representing the
relations of X to Y(s) adjusted for M(s). All of these paths would typically be
quantiﬁed with regression coefﬁcients calculated by multiple linear
regression analyses. The mediation analyses were carried out for variables
in which only when all the paths a(s), b(s) and c(s) to be statistically
signiﬁcant,
25 that is, Model 1 P-values, and Model 2 P-values for ln-leptin
and ln-adiponectin in Table 2 o0.05. In the mediation analysis, the indirect
effect of X on Y through M(s) is deﬁned as the product of path a and path
b, that is, a1b1 and a2b2. And, the total effect of X on Y is the sum of the
direct effect and all of indirect effects: c¼c’ þ a1b1 þ a2b2. We computed
bootstrapped bias-corrected 95% conﬁdence intervals (5000 samples) for
the size of the speciﬁc mediation effects. All multiple mediation analyses
were performed with adjustments for the covariates used in the multiple
regression analysis. We presented standardized regression coefﬁcients (b)
and respective 95% conﬁdence intervals so that comparison of the
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analyses were conducted using the SPSS statistical package for Windows
version 19.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The mean±s.d. age was 47.6±7.1 years, and the mean BMI
was 22.8±2.7kgm
 2 (range 15.0--35.8). Current and ex-smokers
accounted for 29.6% and 21.1% of the sample, respectively.
The geometric means of insulin, adiponectin and leptin were
4.59mUml
 1, 6.78mgml
 1 and 6.58ngml
 1, respectively.
Greater coffee consumption was associated with younger age, a
higher proportion of current smoking and higher total energy
and magnesium intakes (all Po0.001) (Table 1). Coffee
consumption was also associated positively with eGFR
(P¼0.033), but was not related to BMI or physical activity. Coffee
consumption was inversely associated with the intakes of green
tea (P¼0.003).
Coffee consumption was positively and signiﬁcantly associated
with adiponectin levels (Tables 1 and 2) independent of potential
confounding variables (Po0.001). In contrast, it was negatively
associated with leptin (Po0.001), hs-CRP (P¼0.026), triglycerides
(P¼0.026) and liver enzymes (all Po0.001). The inverse associa-
tion of coffee consumption with hs-CRP or triglycerides was
attenuated by additional adjustment for adipocytokines and
became statistically insigniﬁcant, that is, completely explained.
Although the associations of coffee consumption with liver
enzymes were also attenuated by adipocytokines, they were
nevertheless signiﬁcant. Coffee consumption was positively
associated with TC and LDL-C; interestingly, these associations
were strengthened by the inclusion of adipocytokines in the
model. Statistically signiﬁcant associations were not observed
between coffee consumption and high-density lipoprotein cho-
lesterol or glucose metabolism-related markers.
The mediation effects by adiponectin and/or leptin on the
association of coffee consumption were evaluated for hs-CRP,
triglycerides or liver enzymes (Table 3). Adipocytokines explained
43.1% and 61.2% of the associations of coffee consumption with
hs-CRP and triglycerides, respectively. Total mediation effects by
adipocytokines on the associations of coffee consumption with
liver enzymes ranged from 19% for aspartate aminotransaminase
to 33.3% for alanine aminotransaminase.
DISCUSSION
In the present study, we found that the amount of coffee
consumption was associated positively with adiponectin and
inversely with leptin levels. Although coffee consumption was not
related to BMI, our ﬁnding was independent of BMI and potential
confounding variables. These associations of coffee with adipocy-
tokines explained most of its association with triglycerides and
some of those with hs-CRP and liver enzymes. A positive
association of coffee consumption with adiponectin levels is
consistent with previous reports from smaller studies.
18,19 As
adiponectin is secreted from adipocytes,
12 coffee may have effects
on adipocytes. Indeed, one of the major substances that coffee
contains among several hundred other substances, caffeine, in an
experimental study led to the upregulation of peroxisome
proliferator-activated receptor g expression,
26 which is an essential
regulator of adipocyte differentiation and maintenance.
27 As no
association between decaffeinated coffee consumption and
adiponectin was reported,
19 caffeine contained in the coffee
may have acted to increase adiponectin levels.
We observed a statistically signiﬁcant inverse association
between coffee consumption and leptin concentration in the
present study. This was consistent with a previous study that
found a statistically insigniﬁcant inverse association.
21 Although
the pathophysiological signiﬁcance of blood leptin levels is not
fully understood, it is positively correlated with obesity and
inﬂammatory markers.
28 In addition, increased circulating leptin
has been implicated as a marker of leptin resistance.
29,30 As
increased leptin levels may have effects on tissues and organs that
remain sensitive to high leptin concentrations,
31 the decrease of
leptin due to coffee consumption may attenuate such effects.
However, it remains to be elucidated how coffee consumption
might do so.
The level of hs-CRP is a marker of systemic low-grade
inﬂammation. An inverse association of coffee consumption with
hs-CRP was mainly explained by adiponectin and leptin, a ﬁnding
consistent with previous studies reporting the role of leptin and
adiponectin-determining serum CRP levels.
32,33 Our data also
showed that mediation effects of adiponectin and leptin on
hs-CRP were almost equal.
Coffee consumption was inversely associated with triglycerides,
also consistent with previous reports.
4- -6 However, in this study
we were the ﬁrst to reveal that the association was explained
mainly by adiponectin. Coffee may have a potential to improve
hypertriglyceridemia through its effects on adiponectin. In
contrast, LDL-C and TC were positively associated with coffee
consumption. That ﬁnding is also consistent with others even
though consumption of unﬁltered coffee would be very little in
the present sample.
6,34 Our data showed that adipocytokines
negatively mediated the associations of coffee consumption with
TC and LDL-C. In other words, adipocytokines were suggested to
have suppressed
35 coffee’s cholesterol-increasing effect.
36
In line with previous studies,
9,10 coffee consumption was
inversely associated with blood concentration of the liver
enzymes. The associations were partly explained by adipocyto-
kines (from 18.9% in aspartate aminotransaminase to 33.5% in
alanine aminotransaminase). Thus, other factors would likely
explain the associations of coffee consumption with liver enzymes.
We found no associations between coffee consumption and the
markers of glucose metabolism. The present ﬁnding seemingly
contradicts coffee’s reported inverse association with DM in-
cidence.
3 A recent report also showed that coffee consumption
was inversely associated with 2-h postload glucose of oral glucose
tolerance test.
37 We also did not ﬁnd associations of coffee
consumption with DM prevalence or with markers of glucose
Figure 1. Multiple mediation model with two mediators (M1,
ln-adiponectin; M2, ln-leptin) in the context of this study. (1) Total
effect of coffee consumption (X) on each marker (Y(s)) -- path c. (2)
Coffee consumption is hypothesized to exert indirect effects on
each marker through ln-adiponectin (M1) and ln-leptin (M2), and to
exert a direct effect on each marker (path c’(s)). The speciﬁc indirect
effect of X on Y through M1 is deﬁned by the product of the two
paths linking X on Y through that mediator, that is, a1b1; similarly, the
speciﬁc indirect effect of X on Y through M2 is deﬁned by a2b2. The total
indirect effect of X on Y is the sum of the two speciﬁc indirect effects,
that is, a1b1 þ a2b2. The total effect of X on Y is thus the sum of the
direct effect and all of the indirect effects: c ¼ c’ þ a1b1 þ a2b2.
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medication for DM (data not shown). Nevertheless, it would be
possible that the association of coffee consumption with glucose
or insulin could not be observed in apparently healthy young
population with low inter-individual variability. Indeed, it has been
shown that fasting glucose concentrations and insulin sensitivity
show changes starting 3 to 5 years before a diagnosis of DM,
38
and that the onset of DM is often rapid rather than gradual.
39
It has also been reported that the prevalence of DM rapidly rises in
people 60 years or older in Japan.
40 Thus, it may be possible
that examination of older subjects or a sample with greater
inter-individual variability of glucose level might reveal associa-
tions of coffee consumption with markers of the glucose
metabolism.
This study has some potential limitations to be considered. First,
because it is a cross-sectional study, causality can only be inferred.
However, as it is less likely that adipocytokines or other markers
inﬂuence coffee consumption, we consider our inference plausible
that coffee consumption may have primary effects on adipocy-
tokines and other markers investigated in the present study. In
addition, we have excluded subjects who had been medically
treated for several conditions. Although there may be individuals
with other conditions (e.g., these chronic conditions without
medication, gastrointestinal disorders and so on), which could
confound the association, we considered this would have minor
effects. Second, there may be some misclassiﬁcation of daily
coffee consumption doses based on the self-administered
questionnaire. However, such a misclassiﬁcation would have been
Table 1. Baseline characteristics and multivariate-adjusted values of adipocytokines, inﬂammatory markers, lipids, glucose metabolism-related
markers and liver enzymes according to daily coffee consumption, Aichi, 2002
Characteristics and markers Daily coffee consumption P-value
b
o 1 Cup (n¼949) 1 Cup (n¼803) 2--3 Cups (n¼1336) X4 Cups (n¼229)
Male (%) 80 76 75 82 0.010
Age (year) 48.2±7.7 48.2±7.0 46.9±6.8 47.0±6.9 o0.001
Body mass index (kgm
 2) 22.8±2.7 22.9±2.7 22.8±2.7 22.6±2.6 0.51
Smoking status o0.001
Current smoking (%) 20 26 34 50
Past smoking (%) 22 22 21 18
Never (%) 58 52 45 32
Alcohol intake (g per day) 14.9±22.3 15.0±21.0 13.4±19.4 13.4±19.6 0.10
Physical activity
a (%) 19 20 20 22 0.84
Total energy intake (kcal per day) 1918±600 1911±578 1975±577 2117±722 o0.001
Magnesium intake (mg per day) 251±90 255±90 272±86 302±108 o0.001
Sugar use in coffee (%) 22 16 15 10 o0.001
Green tea intake (X2 cups) (%) 56 48 51 48 0.003
eGFR (mlmin
 1 per 1.73m
2) 76.2 (75.4--77.1) 77.2 (76.2--78.2) 77.4 (76.8--78.0) 78.9 (77.5--80.3) 0.033
Adipocytokines
adiponectin (mgml
 1)
c 6.58 (6.40--6.76) 6.68 (6.48--6.88) 6.92 (6.76--7.08) 7.23 (6.84--7.65) 0.005
e
leptin (ngml
 1)
c 4.69 (4.58--4.81) 4.65 (4.53--4.78) 4.50 (4.41--4.59) 4.42 (4.20--4.64) 0.27
Inﬂammatory markers
C-reactive protein (nmoll
 1)
c 4.10 (3.90--4.48) 3.81 (3.52--4.10) 3.52 (3.33--3.81) 4.00 (3.43--4.57) 0.014
TNF-a (pgml
 1)
c,d 12.25 (11.64--12.90) 11.86 (11.25--12.50) 12.05 (11.54--12.59) 12.03 (10.89--13.29) 0.85
IL-6 (pgml
 1)
c,d 1.75 (1.60--1.92) 1.48 (1.34--1.63) 1.56 (1.44--1.69) 1.47 (1.22--1.76) 0.070
Lipids
Total cholesterol (mmoll
 1)
c 5.33 (5.28--5.38) 5.42 (5.36--5.48) 5.42 (5.37--5.46) 5.49 (5.38--5.60) 0.025
e
LDL cholesterol (mmoll
 1)
c 3.05 (3.01--3.10) 3.14 (3.08--3.19) 3.15 (3.12--3.20) 3.21 (3.11--3.31) 0.005
e
HDL cholesterol (mmoll
 1)
c 1.52 (1.50--1.54) 1.56 (1.54--1.59) 1.56 (1.54--1.58) 1.54 (1.49--1.58) 0.012
Triglycerides (mmoll
 1)
c 1.21 (1.17--1.25) 1.15 (1.11--1.19) 1.12 (1.09--1.15) 1.17 (1.09--1.25) 0.006
Glucose metabolism related markers
Glucose (mmoll
 1)
c 5.05 (5.00--5.11) 5.13 (5.07--5.18) 5.05 (5.01--5.09) 5.08 (4.97--5.18) 0.16
Insulin (pmoll
 1)
c 44.7 (42.8--46.8) 46.2 (44.0--48.5) 46.0 (44.3--47.7) 46.0 (42.0--50.3) 0.77
HOMA-IR
c 1.45 (1.38--1.52) 1.52 (1.44--1.60) 1.49 (1.43--1.55) 1.49 (1.35--1.65) 0.65
Liver enzymes
AST (mkatl
 1)
c 0.375 (0.367--0.382) 0.365 (0.358--0.373) 0.357 (0.352--0.363) 0.355 (0.340--0.368) 0.004
e
ALT (mkatl
 1)
c 0.326 (0.317--0.336) 0.319 (0.309--0.329) 0.309 (0.302--0.317) 0.296 (0.277--0.312) 0.007
e
g-GTP (mkatl
 1)
c 0.655 (0.630--0.680) 0.632 (0.607--0.658) 0.583 (0.565--0.603) 0.582 (0.538--0.630) o 0.001
e
Abbreviations: ALT, alanine transaminase; AST, aspartate transferase; BMI, body mass index; CI, conﬁdence interval; ; eGFR, estimated glomerular ﬁltration rate;
g-GTP, g-glutamyltransferase; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistant; hs-CRP, high sensitivity C-reactive
protein; IL-6, interleukin-6; TNF-a denotes tissue necrosis factor-a. Values are percentage, mean±s.d. or geometric mean (95% CI).
aPhysical activity was
deﬁned as moderate and vigorous leisure-time physical activity 3 days or more and 60min or more in total per week.
bDifferences in mean values were tested
by one-way analysis of (co)variance, and differences in the proportions were tested by w
2-test.
cValues were adjusted for age, BMI, smoking status, current
smoking number, alcohol, physical activity, green tea intake, total energy intake, magnesium intake, green tea intake and eGFR.
dn¼199, 175, 265 and 52 from
low to high intake in the analysis of TNF-a and IL-6.
elinear trend tested using polynomial procedure was statistically signiﬁcant (Po0.05).
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ments other than BMI. The possibility that a residual confounding
of body fat distribution exists cannot be excluded. Finally, as all
subjects in the present study were Japanese, the present ﬁndings
may not apply directly to other races.
In conclusion, we found that coffee consumption was
positively associated with adiponectin, and inversely with
leptin levels in middle-aged Japanese workers. Such
associations explained most of the associations of coffee
consumption with triglycerides, and some of those on
hs-CRP and liver enzymes. Further studies are necessary to
determine whether the mediation effects of adipocytokines
on the associations of coffee consumption with metabolic
markers are causal.
Table 2. Multivaria-adjusted associations of coffee consumption (continuous) with adipocytokines, inﬂammatory and glucose metabolism-related
markers, lipids, and liver enzymes with or without further adjustment for adipocytokines, Aichi, 2002 (n¼3317)
Dependent variables Model 1
a Model 2
b
b for coffee consumption P-value b for coffee consumption
g P-value b for ln-adiponectin
e P-value b for ln-leptin
e P-value
Adipocytokines
ln-adiponectin 0.058
d o 0.001 --- --- --- --- --- ---
ln-leptin  0.038
d o 0.001 --- --- --- --- --- ---
Inﬂammatory markers
ln-hs-CRP  0.039
f 0.026  0.022 0.20  0.132 o 0.001 0.237 o 0.001
ln-TNF-a
c  0.017
f 0.68  0.013 0.76  0.015 o 0.001  0.013 o 0.001
ln-IL-6
c  0.057
f 0.16  0.049 0.23  0.052 o 0.001  0.052 o 0.001
Lipids
ln-TC 0.042
f 0.019 0.051 0.004  0.016 0.42 0.207 o 0.001
ln-LDL-C 0.055
f 0.002 0.066 o 0.001  0.073 o 0.001 0.172 o 0.001
ln-HDL-C 0.025
f 0.11 0.006 0.69 0.318 o 0.001  0.025 0.26
ln-triglycerides  0.039
z 0.018  0.015 0.34  0.259 o 0.001 0.232 o 0.001
Glucose metabolism-related markers
ln-Glucose  0.009
f 0.59  0.004 0.81  0.066 o 0.001 0.037 0.15
ln-Insulin 0.010
f 0.57 0.031 0.065  0.121 o 0.001 0.357 o 0.001
ln-HOMA-IR 0.007
f 0.69 0.027 0.11  0.124 o 0.001 0.331 o 0.001
Liver enzymes
ln-AST  0.064
f o 0.001  0.052 0.002  0.066 o 0.001 0.219 o 0.001
ln-ALT  0.059
f o 0.001  0.039 0.012  0.143 o 0.001 0.302 o 0.001
ln-g-GTP  0.068
f o 0.001  0.051 o 0.001  0.128 o 0.001 0.249 o 0.001
Abbreviations: ALT, alanine transaminase; AST, aspartate transferase; g-GTP, g-glutamyltransferase; HDL-C, high-density lipoprotein cholesterol; HOMA-IR,
homeostasis model assessment insulin resistant; hs-CRP, high sensitivity C-reactive protein; IL-6, interleukin-6; LDL-C, low-density lipoprotein cholesterol;
ln-, natural logarithmically transformed; TC, total cholesterol; TNF-a denotes tissue necrosis factor-a. b denotes standardized regression coefﬁcients.
aAdjusted
for sex, age, body mass index, smoking status, cigarettes smoked per day for current smokers, physical activity, total energy intake, intakes of alcohol, green tea
and magnesium, sugar use in coffee, and log-transformed estimated glomerular ﬁltration rate.
bModel 2 adjusted additionally for ln-adiponectin and ln-leptin.
cn¼691 for the analyses of TNF-a and IL-6.
dPath a(s),
ePath b(s),
fPath c(s),
gPath c’(s) in multiple mediation analyses (see Figure 1).
Table 3. Mediation role of adiponectin and leptin on the associations of coffee consumption with hs-CRP, triglycerides and liver enzymes, Aichi, 2002
Dependent
variables
Total effect of coffee
consumption
Multiple mediation analyses
By ln-adiponectin and ln-leptin By ln-adiponectin By ln-leptin
b (95% CI) b (95% CI) Total
mediation
(%)
a
b (95% CI) Speciﬁc
mediation
(%)
a
b (95% CI) Speciﬁc
mediation
(%)
a
ln-hs-CRP  0.039 ( 0.073,  0.005)  0.017 ( 0.025,  0.009) 43.1  0.008 ( 0.013,  0.004) 19.7  0.009 ( 0.016,  0.003) 23.4
ln-TC 0.042 (0.002, 0.017)  0.009 ( 0.015,  0.004)  21.4  0.001 ( 0.005, 0.002)  2.4  0.008 ( 0.014,  0.004)  19.0
ln-LDL-C 0.055 (0.008, 0.032)  0.011 ( 0.019,  0.006)  20.0  0.004 ( 0.008,  0.002)  7.3  0.007 ( 0.012,  0.002)  12.7
ln-
triglycerides
 0.039 ( 0.071,  0.006)  0.024 ( 0.035,  0.014) 61.5  0.015 ( 0.023,  0.007) 38.7  0.009 ( 0.015,  0.004) 22.8
ln-AST  0.065 ( 0.098,  0.032)  0.012 ( 0.019,  0.006) 18.9  0.004 ( 0.008,  0.001) 5.9  0.008 ( 0.014,  0.003) 13.0
ln-ALT  0.059 ( 0.092,  0.027)  0.020 ( 0.030,  0.011) 33.5  0.008 ( 0.013,  0.004) 14.0  0.012 ( 0.020,  0.005) 19.5
ln-g-GTP  0.068 ( 0.098,  0.038)  0.017 ( 0.025,  0.009) 25.2  0.007 ( 0.012,  0.003) 11.0  0.010 ( 0.016,  0.004) 14.1
Abbreviations: ALT, alanine transaminase; AST, aspartate transferase; CI, conﬁdence interval; g-GTP, g-glutamyltransferase; HDL-C, high-density lipoprotein
cholesterol; HOMA-IR, homeostasis model assessment insulin resistant; hs-CRP, high sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol;
ln-, natural logarithmically transformed; TC, total cholesterol. b denotes standardized regression coefﬁcients
aCalculated as proportion of the total indirect
effects to the total effects of coffee consumption: for example,  0.017/( 0.039) 100 for ln-hs-CRP. Negative values indicate that b for coffee consumption
was strengthened by adjustment for ln-adiponectin and ln-leptin.
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